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Malaria during pregnancy is a major factor in infant morbidity and mortality. In this issue of Cell Host and
Microbe, Conroy et al. (2013) propose that C5a, a product of complement cascade activation, counteracts
the placental vascular remodeling response induced byPlasmodium infection and contributes to fetal growth
restriction.In Maori tradition, the placenta (whenua in
the language ofMaori) is buried upon birth
to establish a link between the land (like-
wise called whenua) and the newborn.
Both types of whenua nourish: ‘‘One
allows the foetus to become a baby with
all the potential to become a strong and
healthy adult, and the other sees that
person develop and grow, make their
contribution to society and then be ‘born’
into the spirit of the world’’ (Head and
Head, 2003). Although the placenta is
credited with the developing fetus,
surprisingly little is known about critical
molecules and physiological parameters
that control the functional efficacy of this
fast-growing organ and determine preg-
nancy success.
Fetal growth restriction is a severe
consequence of malarial disease
during pregnancy and thought to result
largely from placental insufficiency.
Much research has been centered on
the pathogenic role of ligand-receptor
interactions between the Plasmodium-
infected erythrocyte and placental
tissues (reviewed by Duffy and Fried,
2005). Parasite antigens expressed on
the surface of infected erythrocytes
are thought to contribute to accu-
mulation of parasitized cells in the
placenta. The best example is var2csa,member of the var (variable surface
antigen) gene family that is selectively
expressed by infected erythrocytes that
accumulate in the placenta (Salanti
et al., 2003). VAR2CSA has strong affinity
to the glycosaminoglycan chondrotin
sulfate A (CSA or C4S) present in high
amounts in the intervillous space and
on the surface of syncytiotrophoblasts,
which contact the maternal blood. The
current pathogenesis model is focused
on linking placental sequestration of
infected erythrocytes to a series of
inflammatory events that can reduce
fetal growth. Cytoadhesion of infected
erythrocytes can activate syncytiotro-
phoblast cells to secrete chemokines,
which attract maternal inflammatory
cells (Lucchi et al., 2008). But how does
inflammation impair maternal-fetal
exchange? Little attention has been
paid to the impact of malaria on physi-
ology of the fast-developing placenta
that in the course of infection may con-
tribute to placental insufficiency.
Recently the pathogenesis paradigm
was challenged by work that addresses
the role of angiogenesis factors (re-
viewed by Conroy et al., 2011), the
coagulation cascade (Avery et al.,
2012), and placental microcirculation
(Moraes et al., 2013).In this issue, Conroy et al. (2013) inves-
tigate potential links between inflamma-
tion, angiogenesis alterations, and fetal
growth restriction in pregnancy-associ-
ated malaria. They focus on activation
of the complement cascade, previously
shown to impair placental vascular re-
modeling in mouse models of miscarriage
or fetal growth restriction (reviewed by
Girardi, 2008). Complement cascade
activation by immune complexes in the
placenta may indirectly contribute to
inflammation. C5a—a protein fragment
released by the activation of C5 comple-
ment component—was shown to be
implicated in tissue injury by inducing
release of reactive oxygen species of
C5a-activated neutrophils. Nevertheless,
in antibody-independent models of
unsuccessful pregnancy, inflammatory
cells indirectly generate C5a fractions
that activate monocytes to produce
soluble vascular endothelial growth factor
(sVEGF), an inhibitor of VEGF. This dereg-
ulation of angiogenic factors is hypothe-
sized to disturb the developing placental
vascularization and as a consequence
impeding babies of getting appropriate
nurturing.
The study by Conroy et al. (2013)
tackles this issue and provides epidemio-
logical data and compelling experimentalFebruary 13, 2013 ª2013 Elsevier Inc. 125
Figure 1. Plasmodium Infection and Placenta Malfunction
Accumulation of infected erythrocytes (IE) in maternal blood spaces (MBS)
leads to inflammatory mononuclear cell recruitment. In this inflammatory mel-
lieu C5a proinflammatory activity contributes to imbalance of angiogenic
factors. As a result of this antiangiogenic response, intraplacental vascular
resistance increases impairing placental perfusion. Altered hemodynamics in
the infected placenta conditionsmaternal blood flow, which promotes infected
erythrocyte accumulation. This cycle amplifies the inflammatory response
leading to placental dysfunction and impacting fetal growth. Therapeutic inter-
vention aiming to decrease C5a generation/signaling could contribute to
promote a proangiogenic response and restore placental perfusion counter-
acting the deleterious effects of placental malaria in the pregnancy outcome.
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Previewsevidence that placental
vascular insufficiency is
a cause of low birth weight
in placental malaria and is
partially mediated by C5a.
The authors observe that
elevated C5a levels in women
infected with Plasmodium
falciparum during pregnancy
are associated with low-
weight babies and altered
levels of angiogenic factors.
This causative chain is
demonstrated using C5a
receptor (C5aR)-deficient
mice, where P. berghei in-
fection during pregnancy re-
sulted in decreased placental
arterial vascular resistance
and correlated with im-
proved fetal viability and birth
weight. Impressively, this
was verified by 3D micro-CT
placental scanning, allowing
the visualization of signifi-
cantly increased vascular
branching in the absence of
C5a. Usage of C5a-deficient
mice was key to distinguish
the placental proangiogenic
response to malaria infec-
tion, from the antiangio-
genic response resulting
from C5a activity. High levels
of C5a elicited by the malaria
infection tilt the balance
of these two concurrent re-
sponses, presumably impair-
ing development of the feto-
placental arterial vasculature
and leading to increased
arterial resistance.
These observations imply
that reduction of intrapla-
cental blood circulation is
harming fetal nurturing and
suggest that reduced pla-
cental perfusion elicited by
other mechanisms involved
in the response to infection
may also contribute to fetal
growth restriction. Using
different mouse and parasite
strains we have observed
decreased placental vascu-larization and reduction of the maternal
blood space in the labyrinth region of
Plasmodium-infected placentas (Ro-
drigues-Duarte et al., 2012). Maternal126 Cell Host & Microbe 13, February 13, 201blood microcirculation in the mouse
placenta was recently shown to promote
sequestration of P. berghei-infected
erythrocytes in maternal blood spaces3 ª2013 Elsevier Inc.with reduced or no flow
(Moraes et al., 2013). The
C5a effect on angiogenesis
could aggravate maternal




nisms, and impoverishing te
whenua (Figure 1). Excessive
fibrin deposition in the in-
fected placenta has been
associated with a dramatic
upregulation of tissue factor
(TF) resulting in a procoagu-
lant and antifibrinolytic re-
sponse (Avery et al., 2012).






shown byConroy et al. (2013),
antibody inhibition of C5a-
C5aR signaling improved
fetal weight of infected preg-
nant mice. This highlights
the C5a-C5aR signaling axis
as a target of therapeutics
that may enable restoration
of placental sufficiency to
protect fetal growth and
viability in the presence of
malaria infection. Focusing
the research on placental
insufficiency is conveying the
notion that poor pregnancy
outcomes of malaria infection
might be mitigated by thera-
peutically restoring placental
functional efficacy indepen-
dent of antiparasite therapies.ACKNOWLEDGMENTS
Luciana Vieira de Moraes is a recip-
ient of a postdoctoral fellowship
from the Fundac¸a˜o para a Cieˆncia
e Tecnologia.REFERENCES
Avery, J.W., Smith, G.M., Owino,
S.O., Sarr, D., Nagy, T., Mwalimu,
S., Matthias, J., Kelly, L.F., Poo-vassery, J.S., Middii, J.D., et al. (2012). PLoS
ONE 7, e31090.
Conroy,A.L.,McDonald,C.R.,Silver,K.L., Liles,W.C.,
and Kain, K.C. (2011). Trends Parasitol. 27, 294–299.
Cell Host & Microbe
PreviewsConroy, A.L., Silver, K.L., Zhong, K., Rennie, M.,
Ward, P., Sarma, V., Molyneux, M.E., Sled, J.,
Fletcher, J.F., Rogerson, S., and Kain, K.C. (2013).
Cell Host Microbe 13, this issue, 215–226.
Duffy, P.E., and Fried, M. (2005). Curr. Top. Micro-
biol. Immunol. 295, 169–200.
Girardi, G. (2008). Am. J. Reprod. Immunol. 59,
183–192.Head, H.M., and Head, S.M. (2003). Aotearoa (New
Zealand: Huia Publishers), pp. 269–286.
Lucchi, N.W., Peterson, D.S., and Moore, J.M.
(2008). Malar. J. 7, 42.
Moraes, L.V., Tadokoro, C.E., Go´mez-Conde, I.,
Olivieiri, D.N., and Penha-Gonc¸alves, C. (2013).
PLoS Pathog. 9, e1003154.Cell Host & Microbe 13,Rodrigues-Duarte, L., de Moraes, L.V., Barboza,
R., Marinho, C.R.F., Franke-Fayard, B., Janse,
C.J., and Penha-Gonc¸alves, C. (2012). Malar. J.
11, 231.
Salanti, A., Staalsoe, T., Lavstsen, T., Jensen,
A.T., Sowa, M.P., Arnot, D.E., Hviid, L., and
Theander, T.G. (2003). Mol. Microbiol. 49,
179–191.February 13, 2013 ª2013 Elsevier Inc. 127
